"Peptide Jilu, Han-Run future" -- The foundation laying ceremony of the pilot test and industrialization project of Han-peptide biomedicine was successfully completed

2020-12-21 17:26:41

Shanghai, Nov. 17 (Chinamil) -- Shandong Tianshan Wool Tex Stock Co., Ltd. 's Han Peptide Biomedical Group holds the ground-laying ceremony for the pilot and industrialization project of Han Peptide biomedical in Gaoqing Economic Development Zone, Shandong Province, Nov. 17, 2020.

Hanpeptide biomedical Group Co., Ltd. with advanced synthetic biology technology, the realization of gene recombinant peptide drugs and new antibody drugs research and development and production, currently focus on diabetes, cancer and other biological similar drugs and innovative drug research and development. Company in shandong, tianjin, jiangsu has more than 6000 square meters of scientific research center, step in shandong and jiangsu lianyungang production base covers an area of 80000 square meters, owns leading to overseas and domestic first-class research and development team, composed of completing the gene editing, enzyme engineering, polypeptide high throughput synthesis and laboratory quality management and control.

The company is currently developing key projects for biosimilar drugs GLP-1, Somalu peptide, Lialu peptide, etc. A class of innovative drugs, somalu peptide compound insulin, Somalu peptide fusion protein, Sting agonist anti-cancer new drugs, etc. There are also collagen, skin care peptides, polyglutamic acid, hyaluronic acid and other skin care raw materials series and health drinks, anti-aging drinks series.

Located in Gaoqing Economic Development Zone, Zibo, Shandong province, the bio-pharmaceutical pilot and industrialization base (Gaoqing Base) covers an area of 95 mu with a total investment of 286 million yuan. The construction projects include human collagen, polypeptide drug workshop, biological drug workshop for the production of GLP-1, such as Lyralu peptide and Somalu peptide, and 20T production lines for medical and cosmetic grade polyglutamic acid and hyaluronic acid. It is planned to complete the construction of adult collagen and polypeptide drug pilot workshop by the end of 2020, and the construction of biopharmaceutical workshop and polypeptide drug raw material workshop by 2021. After the projects have been delivered, the economic benefit is predicted to exceed 2 billion yuan in annual sales revenue and nearly 600 million yuan in profit.

The industrialization project technologies of Gaoqing Base are all derived from the r&d center of the company. Among them, Lillarutide and Somalutide take the lead in adopting the third-generation engineering bacteria as the fermentation chassis, which is advanced and cutting-edge in the world. Human collagen produced by fermentation technology is also the first of its kind in China and fills the technological gap in China. It is a green production technology with broad application fields, great market potential and high added value as a high-end new biological material.

The construction of Hanpeptide Biological Gaoqing Base is the implementation of dezhan Health's strategy of gathering superior resources into a new field of great health. Along with the rapid development of biotechnology and modern biological technology breakthrough and industrialization of rapid evolution, biological economy is speeding up as a new economic form, following the information economy in order to improve people's health provides a new method for the quality of life, as well as catalytic a batch of new biotechnology industry of booming development, biological active peptide industry into the industry's stars. With many years of rich experience in synthetic biology technology, We have been grasping the new trend of peptide industry.

Zibo Gaoqing ranks the second in the investment environment of Shandong Province. Various government departments have done a lot of work to promote the smooth implementation of the project. The construction and operation of Gaoqing Bio-peptide Base is conducive to the agglomeration of upstream and downstream industries and the development of local economy. At present, Hanpeptide Biology has applied for the key project of the conversion of old and new kinetic energy in Shandong. Dexa Health supports the sustainable development of HPEPtidbio, and hPEPtidBio will actively seek independent listing opportunities in domestic and foreign capital markets.

The groundbreaking ceremony of The Gaoqing Base marks that after the completion of the project of anti-liquor products and the production and construction of medical beauty products within this year, Hanpeptide Biological Group has made a key step towards the industrialization construction of biomedicine and high-end new biological materials. "Peptide jilu, Han-dynamic future" -- Han-peptide biology pays tribute to health with green production, shakes the future with medical wisdom, connects the frontier with science, connects the world with innovation, builds the foundation for excellent quality, and enables human health.


版权所有 © 汉肽生物医药集团 鲁ICP备069573500456号

Scan follows the public account